<code id='B281C4F005'></code><style id='B281C4F005'></style>
    • <acronym id='B281C4F005'></acronym>
      <center id='B281C4F005'><center id='B281C4F005'><tfoot id='B281C4F005'></tfoot></center><abbr id='B281C4F005'><dir id='B281C4F005'><tfoot id='B281C4F005'></tfoot><noframes id='B281C4F005'>

    • <optgroup id='B281C4F005'><strike id='B281C4F005'><sup id='B281C4F005'></sup></strike><code id='B281C4F005'></code></optgroup>
        1. <b id='B281C4F005'><label id='B281C4F005'><select id='B281C4F005'><dt id='B281C4F005'><span id='B281C4F005'></span></dt></select></label></b><u id='B281C4F005'></u>
          <i id='B281C4F005'><strike id='B281C4F005'><tt id='B281C4F005'><pre id='B281C4F005'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:47
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          European regulators consider appeal over Amylyx ALS drug
          European regulators consider appeal over Amylyx ALS drug

          PauloAmorim/VWPicsviaAPImagesLONDON—Thisweek,EuropeanregulatorsareconsideringanappealfromAmylyxPharm

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Life sciences deals on track to hit lowest point since 2017

          AdobeIt’snosecretthatbiotechindustryfundinghasfallenfromitsCovidhighs.Butwithjustafewmonthsleftinthe